Companies: 10,795·Total market cap: $144.5T
PharmChem, Inc.

PharmChem, Inc.

PCHMOTCHealthcare
$3.75
+$0.01(+0.27%)
Market Cap$21950509
P/E Ratio
52W High$3.98
52W Low$2.95
Overview

PharmChem, Inc.(PCHM)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PCHM · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.32pchm eps ttm · pchm earnings per shareEarnings history
PE Ratio (TTM)11.8×pchm pe ratio ttm · pchm price to earningsPE Ratio deep dive
Revenue (TTM)$6.2Mpchm revenue ttm · pchm annual revenueFull revenue history
Dividend Yield6.78%does pchm pay dividends · pchm dividend yieldDividend history
Shares Outstanding4.6Mpchm shares outstanding · pchm floatShares outstanding history
Next EarningsTBApchm earnings date · pchm next earningsEarnings history

财务快照

完整财报
FY 2024Revenue$6.1M▲ +1.21% YoY
202220232024
pharmchem, inc. revenue · pchm revenue 2024
FY 2024Net Income$1.4M▲ +63.38% YoY
202220232024
pharmchem, inc. net income · pchm profit 2024
FY 2024EPS$0.30▲ +76.47% YoY
202220232024
pchm eps · pharmchem, inc. earnings per share 2024
TTM:Revenue: $6.2MNet Income: $1.5MEPS: $0.32View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.27%
3M+1.08%
YTD+20.97%
1Y+11.28%
5Y+29.31%

关于 PharmChem, Inc.

CEOThompson Clark CPA
IPO DateJan 8, 2021
Employees9
CountryUS

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, a…

what is pharmchem, inc. · pchm stock overview · pharmchem, inc. company profile · who is pharmchem, inc. ceo · pchm OTC · pharmchem, inc. headquarters · pharmchem, inc. business segments

关于股票概览与关键数据

PharmChem, Inc.(PCHM)是 Medical - Diagnostics & Research 行业的 Healthcare 类公司,于 Jan 8, 2021 在 OTC 上市。截至最近交易日,PCHM 股价为 $3.75,市值约为 $22.0M。过去12个月累计回报 +11.28%,年初至今回报 +20.97%。

2024 财年 PharmChem, Inc. 营收 $6.1M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,PharmChem, Inc.(PCHM)股价为 $3.75,在 OTC 上市,52周区间为 $2.95 – $3.98。

PCHM 最新股价PCHM quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议